Seville Grove (AU)
{name}
{subtitle}
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)
city
~13 mi. (Murdoch, Australia, +144 more cities)
facility
Fiona Stanley Hospital ( Site 4009)
condition
Clear Cell Renal Cell Carcinoma
drug
belzutifan, +3 more drugs
drug type
immunotherapy, +1 more type
A Study of Chemo Only Versus Chemo Plus Nivo With or Without BMS-986205, Followed by Post- Surgery Therapy With Nivo or Nivo and BMS-986205 in Patients With MIBC
city
~13 mi. (Murdoch, Australia, +177 more cities)
facility
St John of God Murdoch Hospital
condition
Bladder Carcinoma
drug
cisplatin, +3 more drugs
drug type
chemotherapy, +1 more type
A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)
city
~13 mi. (Murdoch, Australia, +262 more cities)
facility
Fiona Stanley Hospital - Medical Oncology
biomarker
ER Positive, +1 more biomarker
condition
Breast Adenocarcinoma
drug
giredestrant, +2 more drugs
drug type
hormone therapy, +1 more type
A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That Has Invaded the Muscle Wall of the Bladder and Who Cannot Get Cisplatin, a Type of Medicine Given to Treat Bladder Cancer.
city
~13 mi. (Murdoch, Australia, +137 more cities)
facility
Local Institution
condition
Bladder Urothelial Carcinoma
drug
bempegaldesleukin, +2 more drugs
drug type
immunotherapy, +2 more types
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss
city
~13 mi. (Murdoch, Australia, +170 more cities)
facility
Novartis Investigative Site
biomarker
ER Negative, +4 more biomarkers
condition
Breast Carcinoma
drug
alpelisib, +1 more drug
drug type
chemotherapy, +1 more type
A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
city
~13 mi. (Murdoch, Australia, +126 more cities)
facility
St John of God Hospital - Murdoch
condition
Non-Small Cell Lung Carcinoma
drug
nivolumab, +2 more drugs
drug type
chemotherapy, +1 more type
Pembrolizumab/Vibostolimab Coformulation (MK-7684A) or Pembrolizumab/Vibostolimab Coformulation Plus Docetaxel Versus Docetaxel for Metastatic Non Small Cell Lung Cancer (NSCLC) With Progressive Disease After Platinum Doublet Chemotherapy and Immunotherapy (MK-7684A-002)
city
~13 mi. (Murdoch, Australia, +76 more cities)
facility
Fiona Stanley Hospital-Medical Oncology ( Site 0102)
condition
Non-Small Cell Lung Carcinoma
drug
docetaxel, +1 more drug
drug type
chemotherapy, +1 more type
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
city
~13 mi. (Murdoch, Australia, +4 more cities)
facility
Fiona Stanley Hospital
condition
B-Cell Acute Lymphoblastic Leukemia
drug
blinatumomab, +1 more drug
drug type
chemotherapy, +1 more type
Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy
city
~13 mi. (Murdoch, Australia, +55 more cities)
facility
Fiona Stanley Hospital (Adults only)
condition
Post-Transplant Lymphoproliferative Disorder
drug
tabelecleucel
drug type
cellular therapy, +1 more type